CAS 2018_A_5913 Sabina Ashirbayeva vs FIG

CAS 2018/A/5913 Sabina Ashirbayeva v. International Gymnastics Federation (FIG)

  • Gymnastics (rhythmic)
  • Doping (furosemide, hydrochlorothiazide, chlorothiazide)
  • Athletes’ duty of care to avoid ingestion of prohibited substances
  • Communication of an athlete’s admission to the competent sanctioning body
  • Difference between a plea for mercy and a plea in mitigation

1. An athlete’s duty to take care to avoid an ingestion of prohibited substances axiomatically arises before ingestion, not after it. A breach of that duty cannot be cured by a prompt repentance and avoidance of repetition to which an appellant testifies.

2. While the applicable anti-doping rules do not expressly read that an athlete’s admission, to have any legal relevance, must be communicated to the relevant governing body as opposed to some unrelated third party, no contrary conclusion can be reached. It is an athlete’s duty to ensure that any such admission is communicated to it.

3. A plea for mercy invites a decision outside the relevant rules whereas a plea in mitigation invites a decision within them.



On 6 August 2018 the Disciplinary Committee of the International Gymnastics Federation (FIG) decided to impose a 2 year period of ineligibility on the Kazakh Athlete Sabina Ashirbayeva for multiple anti-doping rule violations. Following notification in June 2018 the Athlete failed to respond to the charges, nor participated in the proceedings.

In this case the Athlete's 4 separate samples tested positive for prohibited substances:

  • Furosemide in April 2017;
  • Hydrochlorothiazide and Clorothiazide in April 2017
  • Hydrochlorothiazide in June 2017;
  • Furosemide in June 2017.

Hereafter in August 2018 the Athlete appealed the FIG Decision with the Court of Arbitration for Sport (CAS). She requested the Panel to set aside the Appealed Decision and plead for a reduced sanction.

The Athlete admitted the violation and denied the intentional use of the substances. She explained that these substances had been used as prescribed medication to relieve swelling in connenction with her disease.

She asserted that in June 2017 she had filed a voluntary early admission of her violations. She alleged that thereupon the sports officials failed to inform the FIG or WADA about this early admission.

The FIG accepted that the Athlete's violations were not intentional and to be considered as one single first violation. Further the FIG contended that the Athlete failed to establish that she had communicated a prompt admission.

Following assessment of the evidence and the Athlete's conduct in this case the Sole Arbitrator determines that:

  • The Athlete's violation was not intentional;
  • The Athlete already had received a reduced sanction of 2 years;
  • She failed to establish that she bears No Significant Fault or Negligence;
  • It was the Athlete's duty to ensure that any early admission was communicated to the FIG.
  • The Athlete's plea for mercy invites a decision outside the relevant rules whereas a plea in mitigation invites a decision within them.

Therefore the Court of Arbitration for Sport decides on 6 March 2019 that:

1.) The appeal filed by Mrs Sabina Ashirbayeva (“the Appellant”) on 14th August 2018 against the decision rendered by Disciplinary Committee of the International Gymnastics Federation on 6th August 2018 is dismissed.

2.) The decision rendered by Disciplinary Committee of the International Gymnastics Federation on 6th August 2018 in the case related to Mrs Sabina Ashirbayeva is confirmed and upheld.

3.) (…).

4.) (…).

5.) All other motions or prayers for relief are dismissed.

Original document

Parameters

Legal Source
CAS Appeal Awards
Date
6 March 2019
Arbitrator
Beloff, Michael J.
Original Source
Court of Arbitration for Sport (CAS)
Country
Kazakhstan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Multiple violations
Negligence
No intention to enhance performance
Sole Arbitrator
Sport/IFs
Gymnastics (FIG) - International Gymnastics Federation
Laboratories
Madrid, Spain: Madrid Anti-Doping Laboratory Agencia Española de Protección de la Salud en el Deporte
Roma, Italia: Laboratorio Antidoping FMSI
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S5. Diuretics and Other Masking Agents
Substances
Chlorothiazide
Furosemide
Hydrochlorothiazide
Medical terms
Legitimate Medical Treatment
Physical injury
Various
Sports officials
Document type
Pdf file
Date generated
12 July 2023
Date of last modification
20 July 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin